DE2747764A1 - Kombinationspraeparat und seine verwendung - Google Patents

Kombinationspraeparat und seine verwendung

Info

Publication number
DE2747764A1
DE2747764A1 DE19772747764 DE2747764A DE2747764A1 DE 2747764 A1 DE2747764 A1 DE 2747764A1 DE 19772747764 DE19772747764 DE 19772747764 DE 2747764 A DE2747764 A DE 2747764A DE 2747764 A1 DE2747764 A1 DE 2747764A1
Authority
DE
Germany
Prior art keywords
group
combination preparation
preparation according
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19772747764
Other languages
German (de)
English (en)
Inventor
David Edward Thorne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of DE2747764A1 publication Critical patent/DE2747764A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19772747764 1976-11-02 1977-10-25 Kombinationspraeparat und seine verwendung Pending DE2747764A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45450/76A GB1552179A (en) 1976-11-02 1976-11-02 Pharmaceutical compositions for treating hyperglycaemia

Publications (1)

Publication Number Publication Date
DE2747764A1 true DE2747764A1 (de) 1978-05-03

Family

ID=10437252

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772747764 Pending DE2747764A1 (de) 1976-11-02 1977-10-25 Kombinationspraeparat und seine verwendung

Country Status (12)

Country Link
JP (1) JPS5362834A (da)
AU (1) AU2998777A (da)
BE (1) BE860307A (da)
DE (1) DE2747764A1 (da)
DK (1) DK485777A (da)
FI (1) FI773213A (da)
FR (1) FR2368959A1 (da)
GB (1) GB1552179A (da)
IL (1) IL53207A0 (da)
NL (1) NL7711993A (da)
SE (1) SE7712328L (da)
ZA (1) ZA776432B (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352667A (en) * 1991-11-22 1994-10-04 Ofer Lider Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
DE102007034102A1 (de) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abriebfeste und rieselfähige Glycocyamin-haltige Formlinge und Verfahren zu deren Herstellung

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE83658T1 (de) * 1988-11-25 1993-01-15 Lubec Gert Behandlung von durch glucose ausgeloester quervernetzung von collagen bei diabetes mellitus-patienten durch arginin, spermidin, kreatin oder agmatin.
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
US5599841A (en) * 1990-02-28 1997-02-04 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
US6008253A (en) * 1991-08-26 1999-12-28 The Upjohn Company Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
EP0854712B1 (en) * 1995-10-11 2003-05-07 Avicena Group, Inc. Use of creatine analogues for the treatment of disorders of glucose metabolism
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
EP1768951A4 (en) * 2004-06-17 2011-06-15 Musc Found For Res Dev NON-NATURAL AMINO ACIDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352667A (en) * 1991-11-22 1994-10-04 Ofer Lider Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
DE102007034102A1 (de) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abriebfeste und rieselfähige Glycocyamin-haltige Formlinge und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
AU2998777A (en) 1979-05-03
IL53207A0 (en) 1977-12-30
DK485777A (da) 1978-05-03
BE860307A (fr) 1978-04-28
GB1552179A (en) 1979-09-12
FR2368959A1 (fr) 1978-05-26
JPS5362834A (en) 1978-06-05
SE7712328L (sv) 1978-05-02
ZA776432B (en) 1978-08-30
NL7711993A (nl) 1978-05-05
FI773213A (fi) 1978-05-03

Similar Documents

Publication Publication Date Title
DE69034223T2 (de) Sertralin zur Behandlung der sozialen Phobie
DE2445584C3 (de) L- bzw. DL-2-Methyl-3- (3', 4'-dihydroxyphenyl)-alanin-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3709621A1 (de) Therapeutisches mittel
CH615920A5 (da)
DE3037770C2 (de) N-Niedrigalkyl-3-phenoxy-1-azetidincarboxamide und diese Verbindungen enthaltende Zubereitungen
DE1643460A1 (de) Carbonsaeureester und -amide und Verfahren zur Herstellung derselben
DD150457A5 (de) Verfahren zur herstellung der(r,r)optisch isomeren verbindungen von labetalol
DE2747764A1 (de) Kombinationspraeparat und seine verwendung
DE2807599A1 (de) Pharmazeutische zusammensetzungen
DE2439859A1 (de) Verfahren zur herstellung von 3-(3,4dihydroxy-phenyl)-serin
DE1793646C3 (de) Glyoxyldithiosemicarbazone Ausscheidung aus 1518228
DE1940566C3 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE60216776T2 (de) Neue piperidin-2,6-dion bisulfatsalze und deren verwendung für die behandlung stressbezogener gemütserkrankungen
DE3836652C2 (da)
DE2835536A1 (de) Verfahren zur erzielung eines antioestrogenen effekts bei warmbluetern, hierfuer geeignete zusammensetzungen und verbindungen sowie verfahren zur herstellung dieser verbindungen
DE3414049C2 (da)
DE2522218B2 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
DE2407016C3 (de) 2-Alkoxybenzoylaminocarbonsäuren, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antipyretische Mittel
DE2103577A1 (de) 5 Azaspiro eckige Klammer auf 2,4 eckige Klammer zu heptane
DE2628642C2 (de) In 2-Stellung substituierte 1,3-Diaza-fünfringkohlenstoffverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE3043446C2 (da)
DE2515142B2 (de) Oral verabfolgbare mittel zur senkung des lipid- und cholesterin- spiegels
DE2163865A1 (de) Hypolipämisches Mittel
DE3423691C1 (de) Arzneimittel zur Bekämpfung von Mykobakteriosen
AT329577B (de) Verfahren zur herstellung von neuen 2- (morpholino) -1-(3-trifluormethylphenyl)-propanderivaten ihren salzen und optischen isomeren

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee